Compounds > 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Arterial Obstructive Diseases

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Arterial Obstructive Diseases in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tulis, DA1
Bohl Masters, KS1
Lipke, EA1
Schiesser, RL1
Evans, AJ1
Peyton, KJ1
Durante, W1
West, JL1
Schafer, AI1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Arterial Obstructive Diseases

ArticleYear
YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function.
    Biochemical and biophysical research communications, 2002, Mar-08, Volume: 291, Issue:4

    Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Blood Platelets; Carotid Stenosis; Cell

2002